Navigate Up
Sign In


​News​​​

07.11.2016
The 14th of November is the World Diabetes Day 2016. Themed "Healthy Diet - Healthy Life", the diabetes societies provide information on diabetes and nutrition throughout Switzerland.
 Learn more.​​

30.10.2016
MSD and SwissCityMarathon Lucerne have once again made 100 charity starts available for a good cause at the 2016 marathon. The total donation will benefit the Make-A-Wish foundation.
 Read more.​​

18.10.2016
MSD and SwissCityMarathon Lucerne have again made a commitment to the marathon on 30 October by donating to the good cause the fees for 100 charity starts. The proceeds will go to the Make-A-Wish Switzerland foundation, which fulfils the dearest wishes of seriously ill children and their families. Find out more.
Read more.​

​​​

​MSD in Switzerland

MSD is one of the world's leading healthcare companies, with its headquarters in the USA (Merck & Co., Inc., Kenilworth, NJ, USA). In Switzerland, MSD is one of the most important pharmaceutical research companies. From our base at Lucerne we serve the Swiss healthcare market and support more than 70 subsidiaries across Europe, Canada, the Middle East, Africa, Brazil, India, and China. Welcome to MSD.

MSD as an employer 
To achieve our ambitious goals, we need the best possible specialist staff and highly committed employees. We offer various positions in a wide range of business areas like for example within our local and international sales organizations, research & development, manufacturing, and within the core departments of our global business located in Lucerne.
Find out more​

 












​The Antibiotics Challenge  

For more than 70 years, MSD has contributed to the discovery and development of novel medicines to combat infectious diseases. The combination with the bio-pharmaceutical company Cubist in January 2015 is an important milestone in this respect to intensify research in view of an increasing resistance against antibiotics – one of the biggest global health challenges - and develop innovative medicines for patients with potentially life-threatening infections diseases caused by bacteria. Cubist’s deep expertise and compelling portfolio and pipeline complement our broad portfolio of Hospital Acute Care. This will help advance a pipeline of candidates that hold the potential for making a meaningful difference in the lives of patients around the world.


General Remark:
Please be aware of the fact that each time when using one of the links in this website, you are leaving the Merck Sharp & Dohme AG, Switzerland (MSD), website and thus our sphere of responsibility. The linked Internet pages have their own terms of use and may be subject to different laws and standards.